Pharmacophylogenomics: Genes, evolution and drug targets

Nature Reviews Drug Discovery

Volumn 2, Issue 8, 2003, Pages 613-623

  Searls, David B ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIDIABETIC AGENT; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN FARNESYLTRANSFERASE INHIBITOR; RETINOID X RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP2; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

DRUG TARGETING; GENE SEQUENCE; GENE STRUCTURE; GENETIC ANALYSIS; HUMAN; MOLECULAR EVOLUTION; MOLECULAR PHYLOGENY; ORTHOLOGY; PARALOGY; PHARMACOGENETICS; PREDICTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; ANIMAL; DRUG DELIVERY SYSTEM; GENE; GENE TARGETING; GENETICS; METHODOLOGY; MOUSE; PHYLOGENY; PHYSIOLOGY; RAT; SPECIES DIFFERENCE;

ANIMALS; DRUG DELIVERY SYSTEMS; EVOLUTION, MOLECULAR; GENE TARGETING; GENES; HUMANS; MICE; PHYLOGENY; RATS; SPECIES SPECIFICITY;

EID: 0042568725     PISSN: 14741776     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrd1152     Document Type: Review

References (148)

1. Eisen, J. A., Kaiser, D. & Myers, R. M. Gastrogenomic delights: a moveable feast. Nature Med. 3, 1076 (1997).
2. Eisen, J. A. Phylogenomics: improving functional predictions for uncharacterized genes by evolutionary analysis. Genome Res. 8, 163-167 (1998).
3. Casari, G., Sander, C. & Valencia, A. A method to predict functional residues in proteins. Nature Struct. Biol. 2, 171-178 (1995).
4. Mirney, L. A. & Gelfand, M. S. Using orthologous and paralogous proteins to identify specificity-determining residues in bacterial transcription factors. J. Mol. Biol. 321, 7-20 (2002).
5. Eisen, J. A. & Wu, M. Phylogenetic analysis and gene functional predictions: phylogenomics in action. Theor. Popul. Biol. 61, 481-487 (2002).
6. Hochachka, P. W. & Monge, C. Evolution of human hypoxia tolerance physiology. Adv. Exp. Med. Biol. 475, 25-43 (2000).
7. Barclay, A. N. Ig-like domains: evolution from simple interaction molecules to sophisticated antigen recognition. Proc. Natl. Acad. Sci. USA 96, 14672-14674 (1999).
8. Jaaro, H., Beck, G., Conticello, S. G. & Fainzilber, M. Evolving better brains: a need for neurotrophins? Trends Neurosci. 24, 79-85 (2001).
9. Wilson, D. R. Evolutionary epidemiology and manic depression. Br. J. Med. Psychol. 71, 375-395 (1998).
10. Gammelgaard, A. Evolutionary biology and the concept of disease. Med. Health Care Philos. 3, 109-116 (2000).
11. Tatusov, R. L. et al. The COG database: new developments in phylogenetic classification of proteins from complete genomes. Nucleic Acids Res. 29, 22-28 (2001).
12. Gilks, W. R. et al. Modeling the percolation of annotation errors in a database of protein sequences. Bioinformatics 18, 1641-1649 (2002).
13. Jones, D. T. & Swindells, M. B. Getting the most from PSI-BLAST. Trends Biochem. Sci. 27, 161-164 (2002).
14. George, R. A. & Heringa, J. Protein domain identification and improved sequence similarity searching using PSI-BLAST. Proteins 48, 672-681 (2002).
15. Holm, L. & Sander, C. Protein folds and families: sequence and structure alignments. Nucleic Acids Res. 27, 244-247 (1999).
16. Todd, A. E., Orengo, C. A. & Thornton, J. M. Plasticity of enzyme active sites. Trends Biochem. Sci. 27, 419-426 (2002).
17. Hou, J., Sims, G. E., Zhang, C. & Kim, S. H. A global representation of the protein fold space. Proc. Natl Acad. Sci. USA 100, 2386-2390 (2003).
18. Thornton, J. W. & DeSalle, R. A new method to localize and test the significance of incongruence: detecting domain shuffling in the nuclear receptor superfamily. Syst. Biol. 49, 183-201 (2000).
19. Koski, L. B. & Golding, G. B. The closest BLAST hit is often not the nearest neighbor J. Mol. Evol. 52, 540-542 (2001).
20. Liao, D. Concerted evolution: molecular mechanism and biological implications. Am. J. Hum. Genet. 64, 24-30 (1999).
21. Amadou, C. Evolution of the MHC class I region: the framework hypothesis. Immunogenetics 49, 362-367 (1999).
22. Swofford, D. L., Olsen, G. J., Waddell, P. J. & Hillis, D. M. in Molecular Systematics (eds Hillis, D. M., Moritz, C. & Mable, B. K.) 407-514 (Sinauer Associates, Sunderland, 1996).
23. Storm, C. E. & Sonnhammer, E. L. Automated ortholog inference from phylogenetic trees and calculation of orthology reliability. Bioinformatics 18, 92-99 (2002).
24. Zmasek, C. M. & Eddy, S. R. Analyzing proteomes by automated phylogenomics using resampled inference of orthologs. BMC Bioinformatics 3, 14 (2002).
25. Koonin, E. V., Mushegian, A. R. & Bork, P. Non-orthologous gene displacement. Trends Genet. 12, 334-336 (1996).
26. Brookfield, J. F. What determines the rate of sequence evolution? Curr. Biol. 10, R410-R411 (2000).
27. Lake, B. G. Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment. Food Chem. Toxicol. 37, 423-453 (1999).
28. Li, W.-H. Molecular Evolution (Sinauer Associates, Sunderland, 1997).
29. Messier, W. & Stewart, C. B. Episodic adaptive evolution of primate lysozymes. Nature 385, 151-154 (1997).
30. Yang, Z. PAML: a program package for phylogenetic analysis by maximum likelihood. Comput. Appl. Biosci. 13, 555-556 (1997).
31. Benner, S. A. et al. Functional inferences from reconstructed evolutionary biology involving rectified databases - an evolutionarily grounded approach to functional genomics. Res. Microbiol. 151, 97-106 (2000).
32. Gaucher, E. A. et al. Predicting functional divergence in protein evolution by site-specific rate shifts. Trends Biochem. Sci. 27, 315-321 (2002).
33. Lopez, P., Casane, D. & Philippe, H. Heterotachy, an important process in protein evolution. Mol. Biol. Evol. 19, 1-7 (2002).
34. Bamshad, M. & Wooding, S. P. Signatures of natural selection in the human genome. Nature Rev. Genet. 4, 99-111 (2003).
35. Smith, J. M. & Haigh, J. The hitch-hiking effect of a favourable gene. Genet. Res. Camb. 23, 23-35 (1974).
36. Przeworski, M. The signature of positive selection at randomly chosen loci. Genetics 160, 1179-1189 (2002).
37. de Groot, N. G. et al. Evidence for an ancient selective sweep in the MHC class I gene repertoire of chimpanzees. Proc. Natl Acad. Sci. USA 99, 11748-11753 (2002).
38. Akey, J. M. et al. Interrogating a high-density SNP map for signatures of natural selection. Genome Res. 12, 1805-1814(2002).
39. Enard, W. et al. Molecular evolution of FOXP2, a gene involved in speech and language. Nature 418, 869-872 (2002).
40. DeLisi, L. E. Speech disorder in schizophrenia: review of the literature and exploration of its relation to the uniquely human capacity for language. Schizophr. Bull. 27, 481-496 (2001).
41. Olson, M. V. & Varki, A. Sequencing the chimpanzee genome: insights into human evolution and disease. Nature Rev. Genet. 4, 20-28 (2003).
42. Rockman, M. V. & Wray, G. A. Abundant raw material for cis-regulatory evolution in humans. Mol. Biol. Evol. 19, 1991-2004 (2002).
43. Akashi, H. Gene expression and molecular evolution. Curr. Opin. Genet. Dev. 11, 660-666 (2001).
44. 2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum. Mol. Genet. 12, 205-216 (2003).
45. Hurst, L. D. & Pal, C. Evidence for purifying selection acting on silent sites in BRCA1. Trends Genet. 17, 62-65 (2001).
46. Durand, D. Vertebrate evolution: doubling and shuffling with a full deck. Trends Genet. 19, 2-5 (2003).
47. Samonte, R. V. & Eichler, E. E. Segmental duplications and the evolution of the primate genome. Nature Rev. Genet. 3, 65-72 (2002).
48. Bailey, J. A. et al. Recent segmental duplications in the human genome. Science 297, 1003-1007 (2002).
49. Friedman, R. & Hughes, A. L. The temporal distribution of gene duplication events in a set of highly conserved human gene families. Mol. Biol. Evol. 20, 154-161 (2003).
50. Smith G. D. et al. TRPV3 is a temperature-sensitive vanilloid receptor-like protein. Nature 418, 186-190 (2002).
51. Wise, A. et al. Molecular identification of high and low affinity receptors for nicotinic acid. J. Biol. Chem. 278, 9869-9874 (2003).
52. Vicker, N. et al. Novel angular benzophenazines: dual topoisomerase I and topoisomerase II inhibitors as potential anticancer agents. J. Med. Chem. 45, 721-739 (2002).
53. Xia, W. et al. Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways. Oncogene 21, 6255-6263 (2002).
54. Lobell, R. B. et al. Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models. Cancer Res. 61, 8758-8768 (2001).
55. Foley, C. L. & Kirby, R. S. 5α-reductase inhibitors: what's new? Curr. Opin. Urol. 13, 31-37 (2003).
56. Heath, R. J., White, S. W. & Rock, C. O. Lipid biosynthesis as a target for antibacterial agents. Prog. Lipid Res. 40, 467-497 (2001).
57. Goldstein, J. M. The new generation of antipsychotic drugs: how atypical are they? Int. J. Neuropsychopharmacol. 3, 339-349 (2000).
58. Hodgkin, J. Seven types of pleiotropy. Int. J. Dev. Biol. 42, 501-505 (1998).
59. Jeffery, C. J. Moonlighting proteins. Trends Biochem. Sci. 24, 8-11 (1999).
60. Copley, S. D. Enzymes with extra talents: moonlighting functions and catalytic promiscuity. Curr. Opin. Chem. Biol. 7, 265-272 (2003).
61. Wistow, G. & Piatigorsky, J. Recruitment of enzymes as lens structural proteins. Science 236, 1554-1556 (1987).
62. Citron, B. A. et al. Identity of 4α-carbinolamine dehydratase, a component of the phenylalanine hydroxylation system, and DCoH, a transregulator of homeodomain proteins. Proc. Natl Acad. Sci. USA 89, 11891-11894 (1992).
63. Sun, Y. J. et al. The crystal structure of a multifunctional protein: phosphoglucose isomerase/autocrine motility factor/neuroleukin. Proc. Natl Acad. Sci. USA 96, 5412-5417 (1999).
64. Gomez, A., Domedel, N., Cedano J., Pinol, J. & Querol, E. Do current sequence analysis algorithms disclose multifunctional (moonlighting) proteins? Bioinformatics 19, 895-896 (2003).
65. Kousteni, S. et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104, 719-730 (2002).
66. Hughes, A. L. Adaptive evolution after gene duplication. Trends Genet. 18, 433-434 (1994).
67. Brett, D. et al. Alternative splicing and genome complexity. Nature Genet. 30, 29-30 (2002).
68. Wagner, A. The role of population size, pleiotropy and fitness effects of mutations in the evolution of overlapping gene functions. Genetics 154, 1389-1401 (2000).
69. Gu, Z. et al. Role of duplicate genes in genetic robustness against null mutations. Nature 421, 63-66 (2003).
70. Zhou, F. C., Lesch, K. P. & Murphy, D. L. Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative. Brain Res. 942, 109-119 (2002).
71. Muoio D. M. et al. Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR)-α knock-out mice. Evidence for compensatory regulation by PPAR-δ. J. Biol. Chem. 277, 26089-26097 (2002).
72. Troy, C. M. et al. Death in the balance: alternative participation of the caspase-2 and -9 pathways in neuronal death induced by nerve growth factor deprivation. J. Neurosci. 21, 5007-5016 (2001).
73. Zhang, J. et al. The tissue-specific, compensatory expression of cyclooxygenase-1 and -2 in transgenic mice. Prostaglandins Other Lipid Mediat. 67, 121-135 (2002).
74. Wang, L. et al. Redundant pathways for negative feedback regulation of bile acid production. Dev. Cell 2, 721-731 (2002).
75. Mesulam, M. M. et al. Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine. Neuroscience 110, 627-639 (2002).
76. Haddad, J. J. Cytokines and related receptor-mediated signaling pathways. Biochem. Biophys. Res. Commun. 297, 700-713 (2002).
77. Dumont, J. E., Pecasse, F. & Maenhaut, C. Crosstalk and specificity in signalling. Are we crosstalking ourselves into general confusion? Cell Signal. 13, 457-463 (2001).
78. Iwamoto, T. et al. STAT and SMAD signalling in cancer. Histol. Histopathol. 17, 887-895 (2002).
79. Takayanagi, H. et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ. Nature 408, 600-605 (2000).
80. Stork, P. J. & Schmitt, J. M. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol. 12, 258-266 (2002).
81. Schwartz, M. A. & Ginsberg, M. H. Networks and crosstalk: integrin signalling spreads. Nature Cell Biol. 4, E65-E68 (2002).
82. B receptors function as heterodimers. Biochem. Soc. Trans. 27, 530-535 (1999).
83. Angers, S., Salahpour A. & Bouvier, M. Biochemical and biophysical demonstration of GPCR oligomerization in mammalian cells. Life Sci. 68, 2243-2250 (2002).
84. North, R. A. Molecular physiology of P2X receptors. Physiol. Rev. 82, 1013-1067 (2002).
85. Czirjak, G. & Enyedi P. Formation of functional heterodimers between the TASK-1 and TASK-3 two-pore domain potassium channel subunits. J. Biol. Chem. 277, 5426-5432 (2002).
86. Liu, Y. & Eisenberg, D. 3D domain swapping: as domains continue to swap. Protein Sci. 11, 1285-1299 (2002).
87. Waxman, D. & Peck, J. R. Pleiotropy and the preservation of perfection. Science 279, 1210-1213 (1998).
88. Galis, F., van Dooren, T. J. & Metz, J. A. Conservation of the segmented germband stage: robustness or pleiotropy? Trends Genet. 18, 504-509 (2002).
89. Lipman, D. J. et al. The relationship of protein conservation and sequence length. BMC Evol. Biol. 2, 20 (2002).
90. Duret, L. & Mouchiroud, D. Determinants of substitution rates in mammalian genes: expression pattern affects selection intensity but not mutation rate. Mol. Biol. Evol. 17, 68-74 (2000).
91. Hastings, K. E. M. Strong evolutionary conservation of broadly expressed protein isoforms in the troponin I gene family and other vertebrate gene families. J. Mol. Evol. 42, 631-640 (1996).
92. Moskowitz, D. W. Is angiotensin I-converting enzyme a "master" disease gene? Diabetes Technol. Ther. 4, 683-711 (2002).
93. Viner, J. L., Umar, A. & Hawk, E. T. Chemoprevention of colorectal cancer: problems, progress, and prospects. Gastroenterol. Clin. North Am. 31, 971-999 (2002).
94. Horowitz, N. H. in Evolving Genes and Proteins (eds Bryson, V. & Vogel, H. J.) 15-23 (Academic Press, New York, 1965).
95. Belfaiza J. et al. Evolution of biosynthetic pathways: two enzymes catalyzing consecutive steps in methionine biosynthesis originate from a common ancestor and possess a similar regulatory region. Proc. Natl Acad. Sci. USA 83, 867-871 (1986).
96. Wilmanns, M. et al. Structural conservation in parallel β/α-barrel enzymes that catalyze three sequential reactions in the pathway of tryptophan biosynthesis. Biochemistry 30, 9161-9169 (1991).
97. Fani, R., Lio, P., Chiarelli, I. & Bazzicalupo, M. The evolution of the histidine biosynthetic genes in prokaryotes: a common ancestor for the hisA and hisF genes. J. Mol. Evol. 38, 489-495 (1994).
98. Alves, R., Chaleil, R. A. & Sternberg, M. J. Evolution of enzymes in metabolism: a network perspective. J. Mol. Biol. 320, 751-770 (2002).
99. 8 barrels: implications for the evolution of metabolic pathways. J. Mol. Biol. 303, 627-641 (2000).
100. Forst, C. V. & Schulten, K. Phylogenetic analysis of metabolic pathways. J. Mol. Evol. 52, 471-489 (2001).
101. Wagner, A. Robustness against mutations in genetic networks of yeast. Nature Genet. 24, 355-361 (2001).
102. Grange, R. W. et al. Functional and molecular adaptations in skeletal muscle of myoglobin-mutant mice. Am. J. Physiol. Cell Physiol. 281, C1487-C1494 (2001).
103. de Groot, A. J., Oerlemans, F. T., Jost, C. R. & Wieringa, B. Changes in glycolytic network and mitochondrial design in creatine kinase-deficient muscles. Muscle Nerve 24, 1188-1196 (2001).
104. Zheng, T. S. et al. Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation. Nature Med. 6, 1241-1247 (2001).
105. Putcha, G. V. et al. Intrinsic and extrinsic pathway signaling during neuronal apoptosis: lessons from the analysis of mutant mice. J. Cell Biol. 157, 441-453 (2002).
106. Marcotte, E. M. et al. Detecting protein function and protein-protein interactions from genome sequences. Science 285, 751-753 (1999).
107. Pellegrini, M. et al. Assigning protein functions by comparative genome analysis: protein phylogenetic profiles. Proc. Natl Acad. Sci. USA 96, 4285-4288 (1999).
108. Marcotte, E. M., Xenarios, I., van der Bliek, A. M. & Eisenberg, D. Localizing proteins in the cell from their phylogenetic profiles. Proc. Natl Acad. Sci. USA 97, 12115-12120 (2000).
109. Goh, C. S. et al. Co-evolution of proteins with their interaction partners. J. Mol. Biol. 299, 283-293 (2000).
110. Goh, C. S. & Cohen, F. E. Co-evolutionary analysis reveals insights into protein-protein interactions, J. Mol. Biol. 324, 177-192 (2002).
111. Bafna, V., Hannenhalli, S., Rice, K. & Vawter, L. Ligand-receptor pairing via tree comparison. J. Comput. Biol. 7, 59-70 (2000).
112. Pazos, F. & Valencia, A. Similarity of phylogenetic trees as indicator of protein-protein interaction. Protein Eng. 14, 609-614 (2001).
113. Koretke, K. K. et al. Evolution of two-component signal transduction. Mol. Biol. Evol. 17, 1956-1970 (2000).
114. Fraser, H. B. et al. Evolutionary rate in the protein interaction network. Science 296, 750-752 (2002).
115. Jordan, I. K., Wolf, Y. I. & Koonin, E. V. No simple dependence between protein evolution rate and the number of protein-protein interactions: only the most prolific interactors tend to evolve slowly. BMC Evol. Biol. 3, 1 (2003).
116. Fraser, H. B., Wall, D. P. & Hirsh, A. E. A simple dependence between protein evolution rate and the number of protein-protein interactions. BMC Evol. Biol. 3, 11 (2003).
117. Maslov, S. & Sneppen, K. Specificity and stability in topology of protein networks. Science 296, 910-913 (2002).
118. Featherstone, D. E. & Broadie, K. Wrestling with pleiotropy: genomic and topological analysis of the yeast expression network. Bioessays 24, 267-274 (2002).
119. Ohno, S. Evolution by Gene and Genome Duplication (Springer, Berlin, 1970).
120. Wilson, A. C., Carlson, S. S. & White, T. J. Biochemical evolution. Annu. Rev. Biochem. 46, 573-639 (1977).
121. Jordan, I. K., Rogozin, I. B., Wolf, Y. I. & Koonin, E. V. Essential genes are more evolutionarily conserved than are nonessential genes in bacteria. Genome Res. 12, 962-968 (2002).
122. Hirsh, A. E. & Fraser, H. B. Protein dispensability and rate of evolution. Nature 411, 1046-1049 (2001).
123. Pal, C., Papp, B. & Hurst, L. D. Genomic function: rate of evolution and gene dispensability. Nature 421, 496-497 (2003).
124. Hirsh, A. E. & Fraser, H. B. Genomic function: Rate of evolution and gene dispensability. Nature 421, 497-498 (2003).
125. Hurst, L. D. & Smith, N. G. C. Do essential genes evolve slowly? Curr. Biol. 9, 747-750 (1999).
126. Conant, G. C. & Wagner, A. GenomeHistory: a software tool and its application to fully sequenced genomes. Nucleic Acids Res. 30, 3378-3386 (2002).
127. Schrag, J. D., Winkler, F. K. & Cygler, M. Pancreatic lipases: evolutionary intermediates in a positional change of catalytic carboxylates? J. Biol. Chem. 267, 4300-4303 (1992).
128. Zhang, J., Dyer, K. D. & Rosenberg, H. F. Evolution of the rodent eosinophil-associated RNase gene family by rapid gene sorting and positive selection. Proc. Natl Acad. Sci. USA 97, 4701-4706 (2000).
129. Wooding, S. P. et al. DNA sequence variation in a 3.7-kb noncoding sequence 5′ of the CYP1A2 gene: implications for human population history and natural selection. Am. J. Hum. Genet. 71, 528-542 (2002).
130. Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. Basic local alignment search tool. J. Mol. Biol. 215, 403-410 (1990).
131. Bromham, L. & Penn, D. The modern molecular clock. Nature Rev. Genet. 4, 216-224 (2003).
132. Mangel, M. & Samaniego, F. J. Abraham Wald's work on aircraft survivability. J. Amer. Statistical Assoc. 79, 259-270 (1984).
133. Hardison, R. C., Oeltjen, J. & Miller, W. Long human-mouse sequence alignments reveal novel regulatory elements: a reason to sequence the mouse genome. Genome Res. 8, 959-966 (1997).
134. Wasserman, W. W., Palumbo, M., Thompson, W., Fickett, J. W. & Lawrence, C. E. Human-mouse genome comparisons to locate regulatory sites. Nature Genet. 26, 225-228 (2000).
135. Bofelli, D. et al. Phylogenetic shadowing of primate sequences to find functional regions of the human genome. Science 299, 1391-1394 (2003).
136. Fitch, W. M. Distinguishing homologous from analogous proteins. Syst. Zool. 19, 99-113 (1970).
137. Van Valen, L. A new evolutionary law. Evol. Theory 1, 1-30 (1973).
138. Black, C. G. & Coppel, R. L. Synonymous and non-synonymous mutations in a region of the Plasmodium chabaudi genome and evidence for selection acting on a malaria vaccine candidate. Mol. Biochem. Parasitol. 111, 447-451 (2000).
139. Woolhouse, M. E., Webster, J. P., Domingo, E., Charlesworth, B. & Levin, B. R. Biological and biomedical implications of the co-evolution of pathogens and their hosts. Nature Genet. 32, 569-577 (2002).
140. Enard, W. et al. Intra- and interspecific variation in primate gene expression patterns. Science 296, 340-343 (2002).
141. Tavazoie, S. et al. Systematic determination of genetic network architecture. Nature Genet. 22, 281-285 (1999).
142. Wang, Y., Schnegelsberg, P. N., Dausman, J. & Jaenisch, R. Functional redundancy of the muscle-specific transcription factors Myf5 and myogenin. Nature 379, 823-825 (1996).
143. Tong, A. H. et al. A combined experimental and computational strategy to define protein interaction networks for peptide recognition modules. Science 295, 321-324 (2002).
144. Ajay, A., Walters, W. P. & Murcko, M. A. Can we learn to distinguish between "drug-like" and "nondrug-like" molecules? J. Med. Chem. 41, 3314-3324 (1998).
145. Muegge, I., Heald, S. L. & Brittelli, D. Simple selection criteria for drug-like chemical matter J. Med. Chem. 44, 1841-1846 (2001).
146. Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23, 4-25 (1997).
147. Veber, D. F. et al. Molecular properties that influence oral bioavailability of drug candidates. J. Med. Chem. 45, 2615-2623 (2002).
148. Hopkins, A. L. & Groom, C. R. The druggable genome. Nature Rev. Drug Discov. 1, 727-730 (2002).